Prostate Cancer

Cognitive Therapy Not More Effective Than Usual Care for Distress Reduction in Advanced PCa

Cognitive Therapy Not More Effective Than Usual Care for Distress Reduction in Advanced PCa

By

Advanced prostate cancer is associated with substantial psychosocial morbidity; therefore, this study was conducted to evaluate whether mindfulness-based cognitive therapy reduces distress in this population.

Guidelines Issued for Prostate MRI After Negative Biopsy

Guidelines Issued for Prostate MRI After Negative Biopsy

Consensus statement presents guidelines for prostate magnetic resonance imaging (MRI) in patients with negative biopsy.

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

[Clinical Medicine Insights: Oncology] This research examines the various mechanisms of resistance to chemotherapy in metastatic CRPC and the potential role of emerging regimens and agents in varying clinical phases of development.

Cancer Patients Benefit From Exercise Both During and After Treatment

Cancer Patients Benefit From Exercise Both During and After Treatment

Studies show better physical function and quality of life for cancer patients who do strength training or aerobic activity.

Second Opinions Rarely Change Prostate Cancer Decisions

Second Opinions Rarely Change Prostate Cancer Decisions

The impact of additional opinions on patient decision-making is limited.

Study Shows Effects of 2012 USPSTF Recommendation Against PSA Screening

Study Shows Effects of 2012 USPSTF Recommendation Against PSA Screening

By

Researchers report on their evaluation of the impact of the 2012 USPSTF recommendation on volumes of prostate biopsy and radical prostatectomy.

Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered

Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered

By

Researchers analyzed data from the NPCR of Sweden to determine whether more US men with prostate cancer would choose active surveillance if it were presented as a treatment option.

Androgen Deprivation Therapy for Prostate Cancer May Increase Dementia Risk

Androgen Deprivation Therapy for Prostate Cancer May Increase Dementia Risk

By

Growing evidence suggests a link between androgen deprivation therapy (ADT) and cognitive dysfunction, but whether it may contribute to the risk of dementia more broadly is unclear. In this study, researchers examined the association of ADT with subsequent development of dementia in patients with prostate cancer.

Early Post-op RT Linked to Worse Functional Outcomes in Prostate Cancer

Early Post-op RT Linked to Worse Functional Outcomes in Prostate Cancer

By

Radiotherapy administered postoperatively within 1 year of radical prostatectomy was associated with worse functional outcomes compared with radiotherapy administered 1 year or more after surgery.

E-HF Radiation Therapy Side Effects Comparable to CF Radiation Therapy in Prostate Cancer

E-HF Radiation Therapy Side Effects Comparable to CF Radiation Therapy in Prostate Cancer

By

Side effects experienced with extremely hypofractionated treatment for intermediate-risk prostate cancer were comparable to those of conventional radiation therapy at 2 years after treatment.

Postdiagnosis Physical Activity Linked to Improved Physical QoL in Prostate Cancer Survivors

Postdiagnosis Physical Activity Linked to Improved Physical QoL in Prostate Cancer Survivors

By

Prostate cancer survivors who maintain or begin recreational physical activity following cancer diagnosis report substantially higher quality of life than those who never exercise or stopped exercising after diagnosis.

Disease-Specific Mortality Comparable Among Treatment Options for Prostate Cancer

By

Disease-specific mortality rates for men with prostate cancer are comparable for 3 treatment options: active surveillance, radical prostatectomy, and external-beam radiotherapy.

Racial Disparity Exists in Receipt of High-Quality Prostate Cancer Care

Racial Disparity Exists in Receipt of High-Quality Prostate Cancer Care

By

Despite that most patients with newly diagnosed prostate cancer receive high-quality care, a racial disparity exists, a recent study has shown.

ADT for up to 36 Months Not Associated With Cognitive Decline

ADT for up to 36 Months Not Associated With Cognitive Decline

By

The long-term use of androgen deprivation therapy (ADT) for up to 36 months does not appear to be associated with cognitive decline in patients with prostate cancer.

Incidence of Early Stage Prostate Cancer Lower After USPSTF Recommendation Against PSA Testing

Incidence of Early Stage Prostate Cancer Lower After USPSTF Recommendation Against PSA Testing

By

Following the USPSTF recommendation against routine PSA testing in all men, incidence rates of early stage prostate cancer in men 50 years and older declined substantially, according to a recent study.

Distress Increases Likelihood of Choosing Surgery for Localized Prostate Cancer

Distress Increases Likelihood of Choosing Surgery for Localized Prostate Cancer

By

Emotional distress is associated with an increased likelihood of opting for surgery among men with localized prostate cancer.

Race Does Not Predict Prostate Cancer Metastasis Development

Race Does Not Predict Prostate Cancer Metastasis Development

By

Race is not associated with the development of metastases in patients with nonmetastatic castration-resistant prostate cancer (CRPC), according to a recently published study.

Predictors Identified for Switching to Active Treatment in Prostate Cancer

Predictors Identified for Switching to Active Treatment in Prostate Cancer

Ethnicity influences patient decision to pursue active treatment and serial biopsies in active surveillance

ADT May Reduce Survival in African American Men With Favorable-risk Prostate Cancer

ADT May Reduce Survival in African American Men With Favorable-risk Prostate Cancer

By

Use of androgen suppression therapy may negatively impact survival in African American patients with favorable-risk prostate cancer.

No Association Between Erectile Dysfunction Drugs and Prostate Cancer

By

Despite previous research demonstrating that the use of PDE-5 inhibitors such as sildenafil, tadalafil, and vardenafil may reduce the risk for developing prostate cancer, a new study suggests that these agents do not prevent prostate cancer.

Salvage Radiotherapy at Lower PSA Levels May be Beneficial

Salvage Radiotherapy at Lower PSA Levels May be Beneficial

By

As salvage radiotherapy (SRT) outcomes may be affected by factors associated with prostatectomy findings, they may be positively affected when used at lower prostate-specific antigen (PSA) levels.

Quality of Life Not Affected by Active Surveillance of Prostate Cancer

Quality of Life Not Affected by Active Surveillance of Prostate Cancer

Choosing no treatment and regular check-ups didn't seem to stress men with low-risk disease

Decision Support and Shared Decision Making Help Patients Choose Plan for Low-Risk Prostate Cancer

Decision Support and Shared Decision Making Help Patients Choose Plan for Low-Risk Prostate Cancer

By

Using an online decision-support tool led to most men with low-risk prostate cancer choosing active surveillance with less conflict about their decision.

Researchers Estimate Familial Prostate Cancer Risk

Researchers Estimate Familial Prostate Cancer Risk

By

Researchers in Sweden have, for the first time, estimated the risk of developing various types of prostate cancer for men with brothers and/or fathers with the disease.

Fluid-Based Biomarkers Found Highly Predictive of Diagnosis and Prognosis in Prostate Cancer

Fluid-Based Biomarkers Found Highly Predictive of Diagnosis and Prognosis in Prostate Cancer

By

Analysis of proteins identified in urine has led to the discovery of proteomic signatures for prostate cancer that have the potential to serve as highly accurate noninvasive biomarkers that can identify aggressive disease before surgery.

Functional Status Linked to Treatment Choice for Prostate Cancer

Functional Status Linked to Treatment Choice for Prostate Cancer

By

Functional status, a person's ability to perform normal activities of daily living, is associated with treatment choice for patients with prostate cancer.

Consumption of Tree Nuts Associated With Reduced Mortality for Patients With Prostate Cancer

Consumption of Tree Nuts Associated With Reduced Mortality for Patients With Prostate Cancer

By

Consumption of tree nuts is associated with lower mortality rates among men with prostate cancer. It did not, however, correlate with a reduced risk of developing prostate cancer.

PET/CT Hybrid Imaging Technique Provides Accurate Guide for Prostate Cancer Biopsy

PET/CT Hybrid Imaging Technique Provides Accurate Guide for Prostate Cancer Biopsy

By

Prostate-specific molecular imaging at initial biopsy and preoperative planning can accurately determine and delineate the extent of prostate cancer. The imaging technique was a type of PET/CT called 68Ga-PSMA PET/CT.

Focal Laser Ablation Feasible and Safe for Treatment of Prostate Cancer

Focal Laser Ablation Feasible and Safe for Treatment of Prostate Cancer

By

Laser heat may soon be an option to treat prostate cancer. Focal laser ablation has been found both feasible and safe in men with intermediate risk prostate cancer.

Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer

Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer

By

Screening PSA levels at midlife could identify men who are at greater risk of developing prostate cancer later in life and who should be monitored more closely.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs